Diaceutics works predominantly with pharmaceutical drug development teams down in the “engine room” of personalized medicine planning, providing those teams the knowledge, evidence, tools and operational structure to effectively commercialize and successfully launch targeted therapies, achieve and exceed their goals for the drug and improve overall return on investment.
Diaceutics also works with upper management heads of personalized medicine centers of excellence, committees and other groups charged with implementing an institutional approach to personalized medicine, within both their R&D and commercial approach.
Finally, Diaceutics works with senior strategy executives reporting to senior management or board members helping them understand the risks and opportunities in personalized medicine – in both the near and long term perspective – and helps to shape strategic thinking for the overall organization in personalized medicine.
Over three-quarters of our business come from repeat clients, such well known companies as Novartis, Pfizer, Boehringer Ingelheim, MedImmune, AstraZeneca and Bristol Myers-Squibb, which speaks to our tangible results and the quality of our engagements. Some recent client engagements and the tangible benefits realized from working with Diaceutics are described in our case studies.
